| Immune checkpoint inhibitors in cancer therapy Y Shiravand, F Khodadadi, SMA Kashani, SR Hosseini-Fard, S Hosseini, ... Current Oncology 29 (5), 3044-3060, 2022 | 323 | 2022 |
| Understanding the tumor microenvironment for effective immunotherapy H Sadeghi Rad, J Monkman, ME Warkiani, R Ladwa, K O'Byrne, N Rezaei, ... Medicinal research reviews 41 (3), 1474-1498, 2021 | 163 | 2021 |
| Targeting BRAF mutations in non-small cell lung cancer CG O’Leary, V Andelkovic, R Ladwa, N Pavlakis, C Zhou, F Hirsch, ... Translational lung cancer research 8 (6), 1119, 2019 | 86 | 2019 |
| Expression of CTGF and Cyr61 in colorectal cancer R Ladwa, H Pringle, R Kumar, K West Journal of clinical pathology 64 (1), 58-64, 2011 | 70 | 2011 |
| Evolution of cancer vaccines—Challenges, achievements, and future directions BQ Tay, Q Wright, R Ladwa, C Perry, G Leggatt, F Simpson, JW Wells, ... Vaccines 9 (5), 535, 2021 | 52 | 2021 |
| Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation? L Masterson, J Howard, J Gonzalez‐Cruz, C Jackson, C Barnett, ... International Journal of Cancer 146 (8), 2305-2314, 2020 | 51 | 2020 |
| High-plex and high-throughput digital spatial profiling of non-small-cell lung cancer (NSCLC) J Monkman, T Taheri, M Ebrahimi Warkiani, C O’leary, R Ladwa, ... Cancers 12 (12), 3551, 2020 | 38 | 2020 |
| The role of circulating biomarkers in lung cancer S Herath, H Sadeghi Rad, P Radfar, R Ladwa, M Warkiani, K O’Byrne, ... Frontiers in Oncology 11, 801269, 2022 | 31 | 2022 |
| Adenoid cystic carcinoma: a review of clinical features, treatment targets and advances in improving the immune response to monoclonal antibody therapy J Nightingale, B Lum, R Ladwa, F Simpson, B Panizza Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1875 (2), 188523, 2021 | 29 | 2021 |
| The cessation of anti-PD-1 antibodies of complete responders in metastatic melanoma R Ladwa, V Atkinson Melanoma Research 27 (2), 168-170, 2017 | 27 | 2017 |
| Dual PET imaging in bronchial neuroendocrine neoplasms: the NETPET score as a prognostic biomarker DL Chan, GA Ulaner, D Pattison, D Wyld, R Ladwa, J Kirchner, BT Li, ... Journal of Nuclear Medicine 62 (9), 1278-1284, 2021 | 25 | 2021 |
| Frontline treatment of epithelial ovarian cancer J Goh, GR Mohan, R Ladwa, S Ananda, PA Cohen, S BARON‐HAY Asia‐Pacific Journal of Clinical Oncology 11, 1-16, 2015 | 21 | 2015 |
| A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine … J Chandra, WP Woo, N Finlayson, HY Liu, M McGrath, R Ladwa, M Brauer, ... Cancer Immunology, Immunotherapy 70, 743-753, 2021 | 19 | 2021 |
| Clinical applications of circulating tumour cells and circulating tumour DNA in non-small cell lung cancer—an update J Kapeleris, M Ebrahimi Warkiani, A Kulasinghe, I Vela, L Kenny, ... Frontiers in oncology 12, 859152, 2022 | 17 | 2022 |
| Maintaining dose intensity of adjuvant chemotherapy in older patients with breast cancer R Ladwa, T Kalas, S Pathmanathan, N Woodward, D Wyld, ... Clinical breast cancer 18 (5), e1181-e1187, 2018 | 16 | 2018 |
| Bridging the research to practice gap: a systematic scoping review of implementation of interventions for cancer-related fatigue management OA Agbejule, NH Hart, S Ekberg, B Koczwara, R Ladwa, C Simonsen, ... BMC cancer 21, 1-14, 2021 | 15 | 2021 |
| Investigating and managing suspected pulmonary embolism in an outpatient setting: the Leicester experience Y Vali, R Ladwa, E Bailie, J Bennett, C Free Thorax 70 (3), 291-293, 2015 | 15 | 2015 |
| Understanding the tumor microenvironment in head and neck squamous cell carcinoma HS Rad, Y Shiravand, P Radfar, R Ladwa, C Perry, X Han, ME Warkiani, ... Clinical & Translational Immunology 11 (6), e1397, 2022 | 14 | 2022 |
| A rare case of omentum invasive prostate cancer: staging with PSMA PET/CT imaging and response to systemic therapy R Ladwa, S Gustafson, E McCaffrey, K Miles, K O’Byrne Clinical Nuclear Medicine 42 (6), e311-e312, 2017 | 13 | 2017 |
| Computed tomography texture analysis of response to second-line nivolumab in metastatic non-small cell lung cancer R Ladwa, KE Roberts, C O’Leary, N Maggacis, KJ O’Byrne, K Miles Lung Cancer Management 9 (3), LMT38, 2020 | 10 | 2020 |
